Lanean...
New serum biomarkers for prostate cancer diagnosis
BACKGROUND: Prostate-specific antigen (PSA) is currently used as a biomarker for diagnosis and management of prostate cancer (CaP). However, PSA typically lacks the sensitivity and specificity desired of a diagnostic marker. OBJECTIVE: The goal of this study was to identify an additional biomarker o...
Gorde:
| Argitaratua izan da: | Clin Cancer Investig J |
|---|---|
| Egile Nagusiak: | , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2014
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4292911/ https://ncbi.nlm.nih.gov/pubmed/25593898 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2278-0513.125802 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|